Additionally, the 36-month beta value for LFMD is 1.45. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for LFMD is 31.20M and currently, short sellers hold a 8.50% ratio of that float. The average trading volume of LFMD on April 19, 2024 was 641.17K shares.
LFMD) stock’s latest price update
The stock price of LifeMD Inc (NASDAQ: LFMD) has surged by 3.44 when compared to previous closing price of 9.87, but the company has seen a -0.10% decline in its stock price over the last five trading sessions. MarketBeat reported 2024-03-19 that LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men’s telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.
LFMD’s Market Performance
LFMD’s stock has fallen by -0.10% in the past week, with a monthly drop of -6.07% and a quarterly rise of 70.17%. The volatility ratio for the week is 6.89% while the volatility levels for the last 30 days are 6.64% for LifeMD Inc The simple moving average for the past 20 days is -0.35% for LFMD’s stock, with a 56.39% simple moving average for the past 200 days.
Analysts’ Opinion of LFMD
Many brokerage firms have already submitted their reports for LFMD stocks, with Craig Hallum repeating the rating for LFMD by listing it as a “Buy.” The predicted price for LFMD in the upcoming period, according to Craig Hallum is $10 based on the research report published on November 30, 2023 of the previous year 2023.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LFMD reach a price target of $7. The rating they have provided for LFMD stocks is “Overweight” according to the report published on July 21st, 2023.
H.C. Wainwright gave a rating of “Buy” to LFMD, setting the target price at $9 in the report published on July 03rd of the previous year.
LFMD Trading at 17.32% from the 50-Day Moving Average
After a stumble in the market that brought LFMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.99% of loss for the given period.
Volatility was left at 6.64%, however, over the last 30 days, the volatility rate increased by 6.89%, as shares sank -11.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.74% upper at present.
During the last 5 trading sessions, LFMD fell by -0.10%, which changed the moving average for the period of 200-days by +113.15% in comparison to the 20-day moving average, which settled at $10.18. In addition, LifeMD Inc saw 23.16% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFMD starting from Velge Bertrand, who purchase 60,000 shares at the price of $3.93 back on Aug 31 ’23. After this action, Velge Bertrand now owns 349,482 shares of LifeMD Inc, valued at $235,800 using the latest closing price.
Velge Bertrand, the Director of LifeMD Inc, purchase 40,000 shares at $3.76 during a trade that took place back on Aug 30 ’23, which means that Velge Bertrand is holding 289,482 shares at $150,400 based on the most recent closing price.
Stock Fundamentals for LFMD
Current profitability levels for the company are sitting at:
- -0.09 for the present operating margin
- 0.86 for the gross margin
The net margin for LifeMD Inc stands at -0.17. The total capital return value is set at -0.61. Equity return is now at value -719.95, with -48.95 for asset returns.
Based on LifeMD Inc (LFMD), the company’s capital structure generated 0.84 points at debt to capital in total, while cash flow to debt ratio is standing at 0.47. The debt to equity ratio resting at 5.38. The interest coverage ratio of the stock is -5.58.
Currently, EBITDA for the company is -7.89 million with net debt to EBITDA at 1.8. When we switch over and look at the enterprise to sales, we see a ratio of 2.61. The receivables turnover for the company is 28.91for trailing twelve months and the total asset turnover is 2.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
In conclusion, LifeMD Inc (LFMD) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
